-
EP2041338
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2041338
| EP2041338 - INTERFERON GAMMA POLYMORPHISMS AS INDICATORS OF SUBJECT OUTCOME IN CRITICALLY ILL SUBJECTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 06.01.2012 Database last updated on 02.09.2024 | Most recent event Tooltip | 06.01.2012 | Application deemed to be withdrawn | published on 08.02.2012 [2012/06] | Applicant(s) | For all designated states THE UNIVERSITY OF BRITISH COLUMBIA University-Industry Liaison Office 103-6190 Agronomy Road Vancouver British Columbia V6T 1Z3 / CA | For all designated states Sirius Genomics Inc. 1125 Howe Street, Suite 603 Vancouver, BC V6Z 2K8 / CA | [2009/14] | Inventor(s) | 01 /
WALLEY, Keith, R. 4172 Coventry Way North Vancouver, British Columbia V7N 4M9 / CA | 02 /
RUSSELL, James, A. 1963 West 35th Avenue Vancouver, British Columbia V6M 1H8 / CA | 03 /
WATTANATHUM, Anan 706 - 1772 Comox Street Vancouver, British Columbia V6G 1P8 / CA | [2009/14] | Representative(s) | Mattsson, Niklas Awapatent AB Drottninggatan 97 P.O. Box 45 086 104 30 Stockholm / SE | [N/P] |
| Former [2009/14] | Mattsson, Niklas Awapatent AB Drottninggatan 97 P.O. Box 45 086 104 30 Stockholm / SE | Application number, filing date | 07719958.6 | 11.06.2007 | [2009/14] | WO2007CA01042 | Priority number, date | US20060812071P | 09.06.2006 Original published format: US 812071 P | [2009/14] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2007140625 | Date: | 13.12.2007 | Language: | EN | [2007/50] | Type: | A1 Application with search report | No.: | EP2041338 | Date: | 01.04.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.12.2007 takes the place of the publication of the European patent application. | [2009/14] | Search report(s) | International search report - published on: | CA | 13.12.2007 | (Supplementary) European search report - dispatched on: | EP | 27.08.2009 | Classification | IPC: | C40B40/06, A61K38/48, A61P29/00, C12Q1/68, C40B40/14 | [2009/14] | CPC: |
C12Q1/6883 (EP,US);
A61K38/4866 (EP,US);
A61P29/00 (EP);
C12Q2600/106 (EP,US);
C12Q2600/118 (EP,US);
C12Q2600/156 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2009/14] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | RS | Not yet paid | Title | German: | INTERFERON-GAMMA-POLYMORPHISMEN ALS INDIKATOREN DES PATIENTENERGEBNISSES BEI SCHWERKRANKEN PATIENTEN | [2009/14] | English: | INTERFERON GAMMA POLYMORPHISMS AS INDICATORS OF SUBJECT OUTCOME IN CRITICALLY ILL SUBJECTS | [2009/14] | French: | POLYMORPHISMES DE L'INTERFÉRON GAMMA UTILISÉS COMME INDICATEURS DE RÉSULTAT CHEZ DES SUJETS GRAVEMENT MALADES | [2009/14] | Entry into regional phase | 09.01.2009 | National basic fee paid | 09.01.2009 | Search fee paid | 09.01.2009 | Designation fee(s) paid | 16.06.2009 | Examination fee paid | Examination procedure | 13.03.2009 | Amendment by applicant (claims and/or description) | 16.06.2009 | Examination requested [2009/31] | 21.12.2009 | Despatch of a communication from the examining division (Time limit: M06) | 17.09.2010 | Reply to a communication from the examining division | 08.06.2011 | Despatch of a communication from the examining division (Time limit: M02) | 19.08.2011 | Application deemed to be withdrawn, date of legal effect [2012/06] | 26.09.2011 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2012/06] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 21.12.2009 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 17.09.2010 | Request for further processing filed | 17.09.2010 | Full payment received (date of receipt of payment) Request granted | 29.09.2010 | Decision despatched | The application is deemed to be withdrawn due to non-payment of the examination fee | 16.06.2009 | Request for further processing filed | 16.06.2009 | Full payment received (date of receipt of payment) Request granted | 22.07.2009 | Decision despatched | Fees paid | Renewal fee | 05.06.2009 | Renewal fee patent year 03 | 08.06.2010 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 30.06.2011 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2005087789 (UNIV BRITISH COLUMBIA [CA], et al) [X] 1-9 * pages 17-18 * * pages 88-109 * * claims 67,68 *; | [X] - YAN S BETTY ET AL, "Effect of factor V Leiden polymorphism in severe sepsis and on treatment with recombinant human activated protein C.", CRITICAL CARE MEDICINE MAY 2004, (200405), vol. 32, no. 5 Suppl, ISSN 0090-3493, pages S239 - S246, XP008109740 [X] 1-9 * the whole document * DOI: http://dx.doi.org/10.1097/01.CCM.0000126122.34119.D1 | [A] - SHAW DAVID ET AL, "Pharmacogenomics in sepsis and septic shock", DRUG DEVELOPMENT RESEARCH, (200504), vol. 64, no. 4, ISSN 0272-4391, pages 181 - 194, XP002541531 [A] * the whole document * DOI: http://dx.doi.org/10.1002/ddr.10433 | [A] - HOLMES C L ET AL, "Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy", CHEST, THE COLLEGE, CHICAGO, IL, US, (20030901), vol. 124, no. 3, ISSN 0012-3692, pages 1103 - 1115, XP009019267 [A] * the whole document * DOI: http://dx.doi.org/10.1378/chest.124.3.1103 | International search | [X]WO0216631 (GENAISSANCE PHARMACEUTICALS [US], et al); | [X]US2005228172 (WANG DAVID G [US]); | [X]US6812339 (VENTER J CRAIG [US], et al); | [YP]WO2006123955 (SYNERGENZ BIOSCIENCE LTD, et al); | [YP]WO2007055602 (SYNERGENZ BIOSCIENCE LTD, et al); | [A]WO0147944 (CURAGEN CORP [US], et al); | [X] - BERNARD G.R. ET AL., "Efficacy and safety of recombinant human activated protein C for severe sepsis", N. ENGL. J. MED., (20010308), vol. 344, no. 10, pages 699 - 709, XP009019299 DOI: http://dx.doi.org/10.1056/NEJM200103083441001 | [Y] - HUANG J. ET AL., "CARAT: a novel method for allelic detection of DNA copy number changes using high density oligonucleotide arrays", BMC BIOINFORMATICS, (20060221), vol. 7, no. 83, pages 1 - 21, XP021013975 DOI: http://dx.doi.org/10.1186/1471-2105-7-83 | [Y] - GAYLORD B.S. ET AL., "SNP detection using peptide nucleic acid probes and conjugated polymers: applications in neurodegenerative disease identification", PROC. NATL. ACAD. SCI. USA, (20050104), vol. 102, no. 1, pages 34 - 39, XP002406317 DOI: http://dx.doi.org/10.1073/pnas.0407578101 | [Y] - RIEDER M.J., GENBANK, Database accession no. (AF375790), XP008092917 | [A] - STASSEN N.A. ET AL., "Interferon-gamma gene polymorphisms and the development of sepsis in patients with trauma", SURGERY, (200208), vol. 132, no. 2, pages 289 - 292, XP008091963 DOI: http://dx.doi.org/10.1067/msy.2002.127167 | [A] - KANTARCI O.H. ET AL., "IFNG polymorphisms are associated with gender differences in susceptibility to multiple sclerosis", GENES IMMUN., (200503), vol. 6, no. 2, pages 153 - 161, XP008090527 | [A] - LATSI P. ET AL., "Analysis of IL-12 p40 subunit gene and IFN-gamma G5644A polymorphisms in Idiopathic Pulmonary Fibrosis", RESPIR. RES., (2003), vol. 4, no. 1, page 6, XP021000008 DOI: http://dx.doi.org/10.1186/1465-9921-4-6 |